Pituitary sarcoma is a rare late complication of radiotherapy for pituitary tumors . Although early case reports involved multiple courses of relatively low-energy radi ation therapy, pituitary sarcoma has been seen with singl e courses of high-energy x-ray or heavy particle radiotherapy . This report describes a fibrosarcoma of the pituitary occurring 5 years after 4,500 rad (45 Gy) of X-irradiation delivered in 20 treatments over 3 weeks by an 8 MeV linear accelerator.
Pituitary sarcoma is a rare late complication of radiotherapy for pituitary tumors . Although early case reports involved multiple courses of relatively low-energy radi ation therapy, pituitary sarcoma has been seen with singl e courses of high-energy x-ray or heavy particle radiotherapy . This report describes a fibrosarcoma of the pituitary occurring 5 years after 4,500 rad (45 Gy) of X-irradiation delivered in 20 treatments over 3 weeks by an 8 MeV linear accelerator.
Case Report
An 18-year-old woman was admitted to the University of Virginia Hospital. For several years prior to admission, she had noted a progressive decrease in vision. She had had on ly two or three scanty menstrual periods sin ce menarche and had been amenorrheic for the previous year. On physical examination, the patient was found to have bilateral optic atrophy, a right temporal hemianopsia, and total blindness in the left eye. Th e rest of the physical and neurological examination was unremarkable except for obesity.
Skull films demonstrated enlarg ement of the left side of the pituitary fossa (fi gs . 1 A and 1 B). Cerebral arteriography revealed slig ht displacement of the left internal carotid and anterior cerebral arteries consistent with suprasellar extension of a pituitary mass.
Endocrine evaluation in cluded a normal T-4 and T-3 resin uptake, a normal plasma cortisol level, and normal urinary steroid excretion . However, hypogonadism was present with undetectable urinary gonadotropin excretion .
A bifrontal crani otomy was performed and a large gray mass was found between the optic nerves. Subtotal intracapsular removal was carried out and pathologic exam in ation of the specimen confirmed the diagnosis of chromophobe adenoma .
The patient did well postoperatively except for transient diabetes inSipidus. She began radiation therapy 7 weeks after admission . A total of 4,500 rad (45 Gy) was delivered in 20 treatments over 3 weeks using a three-field technique with an 8 MeV linear accelerator.
Th e patient was empirically placed on thyroid and steroid replacement therapy and followed closely. She was electively admitted 4 years later for reevaluation. Serum prolactin levels were markedly elevated, ranging from 375 to 539 ng / ml (normal , < 20). The basal Received October 16, 1979 .; accepted after revision Apri l 2, 198 0 . serum growth hormone and th at aft er in suli n-induced hypoglyce mi a were both undetec tabl e. Other endocrin e func ti on appeared unc hanged . Th e pituitary fossa had diminished and calc ifica ti ons had developed above th e se ll a turci ca.
The development of pain in th e left eye prompted readmission 10 months later. In addition to th e previ ous visual fi eld defec ts, she had ptosis and c omplete ophthalmopl egia on th e left sid e. Skull films showed displacem ent of th e dural c lips upward out of th e pituitary fossa. Th e small calcification s were also displaced upward above the sella turci ca ( fig . 1 C) . CT showed a larg e enh anc ing mass eroding the left side of the sella turc ica (fig s. 1 D and 1 E) . Th e mass contained small calcifications and ex tended into th e suprasell ar cistern deforming the upper brainstem . Cerebral angiography again showed displacement of the supraclinoid intern al ca rotid and the proximal anterior c erebral arteri es. In addition, neovascularit y was present in the left side of the pitu itary fossa ( fig . 1 F) .
Dynamic endocrin e testing showed the pati ent to be defi c ient in growth hormone, gonadotrophin , thyrotropin , and corti cotropin. However, the serum prolactin level s remained el evated at 168-2 22 ng / ml. She was thus believed to have a recurrent , expanding pituitary ad enoma and was continued on thyroid and steroid replacement. Because the tumor was believed to be unresec tabl e , bromocriptine (2 .5 mg three times a day) was started in an attempt to retard tumor growth [1] [2] [3] .
The patient was readmitted 3 months later with nausea, vo miting , and lethargy . Skull films showed marked destru c tion of th e dorsum sellae. CT and angiography demonstrated marked interval enl argement of the tumor.
Because of her deteriorating condition, palli ativ e surgery was undertaken . A large tumor was found extending out of th e sell a and subtotal removal was performed . Pathologi c examinati on of the surgical specimen showed a histology that was markedly different from the orig in al tumor and now represented a fibrosarcoma. Th e postoperative course was compli cated and sh e died 20 days after surgery. patients who had previously received radiation therapy for pituitary adenoma. Since the report of those ttiree patients, 11 additional patients have now been reported with postirradiation pituitary fibrosarcoma [5] [6] [7] [8] [9] [10] [11] . Other sarcomas occurring in this context have also been reported: osteosarcoma [12] , malignant fibrous histiocytoma [13] , and undifferentiated sarcoma [14, 15] .
The radiation treatments used in these cases are summarized in table 1. Seven patients were acromegalic; 11 patients had chromophobe adenomas. The time span between the initial radiation therapy and diagnosis of sarcoma ranged from 4 to 27 years (median, 10).
Goldberg et al. [14] raised the possibility that multiple courses of radiation therapy might increase the risk of developing sarcoma. However, most cases reported sub- Waltz and Brownell [8] put forth the hope that use of higher energy or heavy-particle radiotherapy might eliminate the appearance of postirradiation sarcomas. Although the majority of reported cases received orthovoltage radiation, the most recent ones have involved the higher energy radiation of cobalt-60, betatron, and linear accelerator therapy and the heavy particles of cyclotron radiotherapy.
Waltz and Brownell [8] also called attention to the fact that prior to about 1950, the dose of radiation to pituitary adenomas varied between 1,500 and 2,500 rad (15-25 Gy). No case of sarcoma has been reported resulting from treatment during that time . Postirradiation sarcomas have all been associated with doses exceeding 3,000 rad (30 Gy). This late complication might be avoided by using radiation doses below this level. However, the best results of radiotherapy for chromophobe adenoma, either as the primary treatment or after surgery, have been obtained with doses of 3,000-5,000 rad (30-50 Gy) [15] . Conventional supervoltage irradiation of the same magnitude has also been required for effective treatment of acromegaly [16] .
Heavy-particle therapy capable of giving good control without surgery has used doses of 3,500-10,000 rad (35-100 Gy) or higher [1 7] .
It thus seems that all current forms of radiation used in the treatment of pituitary adenoma are capable of inducing fibrosarcoma. Since irradiation is an effective therapy for pituitary adenoma and the occurrence of fibrosarcoma is only a rare complication, it will continue to be used . It is therefore important for physicians to be aware of this complication. The sudden " recurrence" of a rapidly growing, locally destructive sellar mass in a patient who was effectively treated for pituitary adenoma with radiotherapy years earlier should suggest the diagnosis of fibrosarcoma . Early diagnosis may make surgery feasible as the only hope for palliation .
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